Population Health and Disparities
Our work in Population Health and Disparities
-
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.
Categorized in -
Alternatives to the QALY for Comparative Effectiveness Research
We now have useful and valid alternatives that allow for the assessment and valuation of treatments that improve population health without discriminating against vulnerable patient populations.
Categorized in -
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
Categorized in -
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation
Abstract The generalized risk-adjusted cost-effectiveness (GRACE) model generalizes conventional cost-effectiveness analysis (CEA) by introducing diminishing returns to Health-Related Quality of Life (QoL). This changes CEA practice in three ways: (1) Willingness to pay (WTP) increases exponentially with untreated illness severity or pre-existing permanent disability, and WTP ends up lower for mild diseases but higher for […]
Categorized in -
Shuttered Pharmacies: A Major Hole in Healthcare
Pharmacy deserts contribute to persistent racial and ethnic health disparities. Why is this happening and what can be done to ensure access to pharmacy services?
-
Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness
Abstract Objectives Both private sector organizations and governmental health agencies increasingly use illness severity measures to adjust willingness-to-pay thresholds. Three widely discussed methods—absolute shortfall (AS), proportional shortfall (PS), and fair innings (FI)—all use ad hoc adjustments to cost-effectiveness analysis methods and “stair-step” brackets to link illness severity with willingness-to-pay adjustments. We assess how these methods […]
Categorized in -
American Life in Realtime: a Benchmark Registry of Health Data for Equitable Precision Health
Applying artificial intelligence and machine learning to person-generated health data allows unprecedented assessment of associations between everyday life and health outcomes.
Categorized in -
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Categorized in -
High-Tech Map Promotes Access to Medicine and Pharmacy Services
A USC-developed interactive mapping tool shows the location of every pharmacy in the United States — and which neighborhoods are “pharmacy deserts.”
-
Using Dynamic Microsimulation to Project Cognitive Function in the Elderly Population
A long-term projection model based on nationally representative data and tracking disease progression across Alzheimer’s disease continuum is important for economics evaluation of Alzheimer’s disease and other dementias (ADOD) therapy.
Categorized in